Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and p53 Status.

Gynecologic oncology reports·2026

Same author

The multidisciplinary management of a patient with infected iliocaval stents and uterine cancer invasion.

Journal of vascular surgery cases and innovative techniques·2026

Same author

Efficacy of Laparoscopic-Assisted Transversus Abdominus Plane (LA-TAP) Block for Minimally Invasive Gynecologic Surgeries (MIGS): A Randomized Controlled Trial.

Journal of minimally invasive gynecology·2026

Same author

Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same author

A Rare Case of Giant Leiomyoma in the Space of Retzius.

Case reports in obstetrics and gynecology·2026

Same author

Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer case.

Gynecologic oncology reports·2025

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Cervical carcinosarcoma: a case report.

Alireza Abidi¹, Kirsten Menn, Andrea Sherman

¹Department of Obstetrics and Gynecology, Bridgeport Hospital-Yale New Haven Health, Bridgeport, Connecticut, USA. alireza.abidi@ucdmc.ucdavis.edu

The Journal of Reproductive Medicine

|March 25, 2008

Summary

Cervical carcinosarcomas are rare and aggressive cancers. Early diagnosis and treatment may lead to a better prognosis compared to uterine corpus carcinosarcomas, warranting further research into multimodal therapies.

Related Experiment Videos

Last Updated: Jul 6, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Area of Science:

Gynecologic Oncology
Pathology
Surgical Oncology

Background:

Carcinosarcomas are rare, aggressive neoplasms of the female genital tract.
Cervical carcinosarcomas are exceptionally rare, with limited prior case reports.
These tumors are generally associated with a poor prognosis.

Observation:

A case of a 68-year-old woman with cervical carcinosarcoma is presented.
The patient underwent surgical resection and pelvic radiation therapy.
She remained disease-free for 18 months post-treatment.

Findings:

Cervical carcinosarcomas appear to present at earlier stages than uterine corpus counterparts.
This earlier presentation facilitates timely diagnosis and treatment.
Cervical carcinosarcomas may have a more favorable prognosis than uterine corpus tumors.

Implications:

The findings suggest a potentially better overall prognosis for cervical carcinosarcomas.
Further research is recommended to explore aggressive, multimodal therapeutic strategies.
The goal is to improve cure rates for cervical carcinosarcomas.